Showing 6,008 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Changing treatment

Caveat emptor: Seven things every patient should know about switching from efavirenz to dolutegravir

Editor's pick
Spotlight
25 November 2019
Treatment interruptions

Second case of unintended HIV transmission during HIV cure study prompts questions about PrEP provision

News
22 November 2019
New & experimental HIV treatments

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention

Editor's pick
ViiV Healthcare press release
21 November 2019
Drug interactions & pharmacokinetics

One-third of people living with HIV in rural Tanzania report clinically relevant drug-drug interactions

News
21 November 2019
Drug interactions & pharmacokinetics

Polypharmacy: What Is It? And How Does It Affect People With HIV?

Editor's pick
TheBodyPro
20 November 2019
Bad science & bogus treatments

Retraction: Questioning the HIV-AIDS hypothesis: 30 years of dissent

Editor's pick
Frontiers in Public Health
18 November 2019
PrEP science

How do we deal with apparent cases of PrEP failure?

News
15 November 2019
PrEP science

96-week results of DISCOVER PrEP trial presented at European AIDS Conference

News
14 November 2019
Treatment simplification strategies

Options for two-drug simplification expand

News
14 November 2019
Kidney problems

Tenofovir (TDF) does not increase risk of kidney disease in people at low risk

News
13 November 2019
Bad science & bogus treatments

Another case of HIV cure hype-atitis

Editor's pick
HIV Cure
13 November 2019
Treatment simplification strategies

Jitters Over New Two-Drug HIV Regimens

Editor's pick
Medscape (requires free registration)
12 November 2019
HIV treatment

Biktarvy Maintains High Efficacy for Three Years in Clinical Trials

Editor's pick
POZ
11 November 2019
Weight gain & lipodystrophy

Dolutegravir and raltegravir cause changes to fat cells

News
11 November 2019
Bad science & bogus treatments

Gene Therapy and 'Cure': Tone It Down!

Editor's pick
Science
11 November 2019
Side effects

Weight gain after switching to integrase inhibitor treatment is small in Dutch and Swiss cohorts

News
11 November 2019
Treatment guidelines

New European HIV guidelines cater for multiple needs

News
10 November 2019
Side effects

ADVANCE study shows high frequency of major weight gain in women receiving dolutegravir with TAF

News
8 November 2019
Side effects

Weight gain on HIV treatment: drug combinations, not single drugs, need to be focus of quest for cause

News
8 November 2019
Bad science & bogus treatments

Misleading Ads About PrEP Are Threatening Progress to End the HIV Epidemic. They Must Be Removed.

Editor's pick
TheBodyPro
7 November 2019
Resistance

FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations

Editor's pick
Food & Drug Administration
6 November 2019
HIV treatment

Learning the Names of HIV Drugs Is Horribly Difficult — Here’s Why

Editor's pick
HIV and ID Observations
4 November 2019
Bone & joint problems

Switching from TDF to TAF associated with improvements in bone mineral density in people over 60

News
4 November 2019
Women

Women and HIV in the United Kingdom

Editor's pick
Public Health England
2 November 2019